Regulation of somatotrophic and lactogenic binding sites in mouse liver membranes.
Both somatotrophic and lactogenic binding sites increase markedly in pregnant mouse liver membranes. The regulatory mechanisms of these binding sites involved in pregnancy are studied. The study of the effects of various hormone administration to female mice reveals that oestradiol increases and testosterone decreases lactogenic binding sites, and that other hormones affect neither somatotrophic nor lactogenic binding sites. Hysterectomy, adrenalectomy or foetectomy of pregnant mice cause a remarkable reduction of somatotrophic binding sites to the level observed in non-pregnant or post-partum animals. In contrast, the lactogenic binding sites are not influenced by these treatments. Replacement with corticosterone after adrenalectomy does not prevent the decrease of somatotrophic binding sites. The contents of placental lactogen from both adrenalectomized and foetectomized pregnant mice are similar to those of the normal pregnant group. These observations indicate that the regulatory mechanisms modulating somatotrophic and lactogenic binding activities are quite different and that increased somatotrophic binding sites during pregnancy are supported by the factor(s) generated in the foeto-placental unit and maternal adrenal gland.
D000315:Adrenalectomy; D000818:Animals; D001665:Binding Sites; D002369:Castration; D002462:Cell Membrane / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000502:physiology; D013006:Growth Hormone / Q000378:metabolism*; D007044:Hysterectomy; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010928:Placental Lactogen / Q000378:metabolism*; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D011869:Radioligand Assay; D013739:Testosterone / Q000494:pharmacology
D013739:Testosterone; D004958:Estradiol; D011388:Prolactin; D013006:Growth Hormone; D010928:Placental Lactogen